754226-38-5

Usage

Uses

Used in Organic Synthesis:
2-(3,4-Difluoro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane is used as a building block in the synthesis of pharmaceuticals, agrochemicals, and materials for its high stability and reactivity, which are crucial for creating complex organic molecules.
Used in Cross-Coupling Reactions:
In the field of organic chemistry, 2-(3,4-Difluoro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane is utilized as a reagent in cross-coupling reactions, which are essential for forming carbon-carbon bonds, a fundamental aspect of organic synthesis.
Used as a Precursor in Heterocyclic Compound Synthesis:
2-(3,4-Difluoro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane is used as a precursor in the synthesis of heterocyclic compounds, which are important in various applications, including pharmaceuticals and agrochemicals, due to their diverse chemical properties and biological activities.
Used in Medicinal Chemistry and Drug Discovery:
2-(3,4-Difluoro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane has potential applications in medicinal chemistry and drug discovery, where it can be used to modulate biological processes, contributing to the development of new therapeutic agents.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-(3,4-Difluoro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane is used as a key intermediate in the development of new drugs, leveraging its reactivity and stability to create novel therapeutic molecules.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, 2-(3,4-Difluoro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane is used as a building block for the synthesis of new agrochemicals, helping to develop more effective and environmentally friendly products for agricultural use.

Upstream product

• 134364-69-5 2.3-difluoroanisole 
• 73183-34-3 bis(pinacol)diborane 
• 261762-35-0 5-bromo-1,2-difluoro-3-methoxy-benzene 

Relevant academic research and scientific papers

NOVEL HETEROCYCLIC COMPOUNDS

The invention provides novel heterocyclic compounds having thegeneral formula (I), and pharmaceutically acceptable salts thereof, wherein R1 to R4, m, n, and p are as described herein. Formula (I). Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.

DERIVATIVES OF MACROCYCLIC N-ARYL-2-AMINO-4-ARYL-PYRIMIDINE POLYETHERS AS INHIBITORS OF FTL3 AND JAK

The present invention relates to a compound with the following formula: formula (I) or a salt and/or a pharmaceutically acceptable solvate thereof, in particular for use as a drug, in particular in the treatment of cancer, as well as to the pharmaceutical compositions that contain same and to the methods for preparing same.

C-H Functionalization at Sterically Congested Positions by the Platinum-Catalyzed Borylation of Arenes

Despite significant progress in the area of C-H bond functionalization of arenes, no general method has been reported for the functionalization of C-H bonds at the sterically encumbered positions of simple arenes, such as mesitylene. Herein, we report the development of the first platinum-based catalyst for C-H borylation of arenes and heteroarenes. Notably, this method exhibited high tolerance toward steric hindrance and provided rapid access to a series of 2,6-disubstituted phenylboronic esters, valuable building blocks for further elaborations.